<tei>
    <teiHeader>
        <fileDesc xml:id="_Kumanomidou 2022.pdf"/>
    </teiHeader>
    <text xml:lang="en">


		<figure type="table">

            <head>Table </head>
 
            <label>1<lb/> </label>
<lb/> 
            <table>EQ-5D-5L questionnaire.<lb/> Under each heading, Please check the ONE box that best describes your health<lb/> TODAY.<lb/> MOBILITY<lb/> I have no problems in walking about<lb/> ,<lb/> I have slight problems in walking about<lb/> ,<lb/> I have moderate problems in walking about<lb/> ,<lb/> I have severe problems in walking about<lb/> ,<lb/> I am unable to walk about<lb/> ,<lb/> SELF-CARE<lb/> I have no problems washing or dressing myself<lb/> ,<lb/> I have slight problems washing or dressing myself<lb/> ,<lb/> I have moderate problems washing or dressing myself<lb/> ,<lb/> I have severe problems washing or dressing myself<lb/> ,<lb/> I am unable to wash or dress myself<lb/> ,<lb/> USUAL ACTIVITIES (e.g. work, study, housework,<lb/> family or leisure activities)<lb/> I have no problems doing my usual activities<lb/> ,<lb/> I have slight problems doing my usual activities<lb/> ,<lb/> I have moderate problems doing my usual activities<lb/> ,<lb/> I have severe problems doing my usual activities<lb/> ,<lb/> I am unable to do my usual activities<lb/> ,<lb/> PAIN/DISCOMFORT<lb/> I have no pain or discomfort<lb/> ,<lb/> I have slight pain or discomfort<lb/> ,<lb/> I have moderate pain or discomfort<lb/> ,<lb/> I have severe pain or discomfort<lb/> ,<lb/> I have extreme pain or discomfort<lb/> ,<lb/> ANXIETY/DEPRESSION<lb/> I am not anxious or depressed<lb/> ,<lb/> I am slightly anxious or depressed<lb/> ,<lb/> I am moderately anxious or depressed<lb/> ,<lb/> I am severely anxious or depressed<lb/> ,<lb/> I am extreamely anxious or depressed<lb/> ,<lb/> </table>
<lb/> 
            <figDesc>drugs, including oral steroids, during the pollen season. The<lb/> detailed characteristics of the patients are shown in Table 2. Writ-<lb/>ten informed consent was obtained from each subject, and the<lb/> study was approved by the institutional review board of each<lb/> hospital (13-B-322, 1903-042, 806, H30-19, H31-06, 36 and 019-<lb/>65 at the International University of Health and Welfare Hospital,<lb/> Okayama University Hospital, Kagawa Prefectural Central Hospital,<lb/> Kagawa Rosai Hospital, Ibara City Hospital, Himeji Red Cross Hos-<lb/>pital, and Himeji St. Mary&apos;s Hospital, and respectively).</figDesc>
		</figure>


		<figure type="table">

            <head>Table </head>
 
            <label>2<lb/> </label>
<lb/> 
            <figDesc>Patients&apos; characteristics.<lb/> </figDesc>
<lb/> 
            <table>2019<lb/> (n ¼ 80)<lb/> 2020<lb/> (n ¼ 158)<lb/> Age, mean ± SD, years<lb/> (minemax)<lb/> 46.7 ± 17.5<lb/> (18e79)<lb/> 47.3 ± 17.8<lb/> (18e79)<lb/> Sex (male:female)<lb/> 32:48<lb/> 70:88<lb/> Concomitant allergic<lb/> disease<lb/> None<lb/> 63<lb/> 84<lb/> Asthma<lb/> 5<lb/> 21<lb/> Atopic dermatitis<lb/> 1<lb/> 18<lb/> Drug allergy<lb/> 8<lb/> 15<lb/> Others<lb/> 2<lb/> 22<lb/> Unknown<lb/> 1<lb/> 8<lb/> Treatment for JCP<lb/> None<lb/> 35<lb/> 46<lb/> Early interventional<lb/> pharmacotherapy<lb/> 8<lb/> 4 1<lb/> Post-onset<lb/> pharmacotherapy<lb/> 30<lb/> 54<lb/> Allergen immunotherapy<lb/> 3<lb/> 10<lb/> Surgery (eg. Laser<lb/> vaporization)<lb/> 4<lb/> 3<lb/> Unknown<lb/> 0<lb/> 4<lb/> </table>
<lb/> 
            <head>Table </head>
 
            <label>3<lb/> </label>
<lb/> 
            <figDesc>Correlation between individual symptom scores and utility.<lb/> </figDesc>
<lb/> 
            <table>Year<lb/> r<lb/> 95% CI<lb/> P<lb/> Sneezing<lb/> 2019 þ 2020<lb/> À0.419<lb/> À0.519 ~À0.309<lb/> &lt;0.001<lb/> 2019<lb/> À0.414<lb/> À0.581 ~À0.214<lb/> &lt;0.001<lb/> 2020<lb/> À0.441<lb/> À0.558 ~À0.305<lb/> &lt;0.001<lb/> Rhinorrhea<lb/> 2019 þ 2020<lb/> À0.400<lb/> À0.502 ~À0.288<lb/> &lt;0.001<lb/> 2019<lb/> À0.426<lb/> À0.590 ~À0.227<lb/> &lt;0.001<lb/> 2020<lb/> À0.413<lb/> À0.534 ~À0.274<lb/> &lt;0.001<lb/> Congestion<lb/> 2019 þ 2020<lb/> À0.440<lb/> À0.537 ~À0.331<lb/> &lt;0.001<lb/> 2019<lb/> À0.484<lb/> À0.636 ~À0.295<lb/> &lt;0.001<lb/> 2020<lb/> À0.422<lb/> À0.543 ~À0.285<lb/> &lt;0.001<lb/> Eye itching<lb/> 2019 þ 2020<lb/> À0.338<lb/> À0.446 ~À0.220<lb/> &lt;0.001<lb/> 2019<lb/> À0.365<lb/> À0.541 ~À0.158<lb/> &lt;0.001<lb/> 2020<lb/> À0.335<lb/> À0.466 ~À0.188<lb/> &lt;0.001<lb/> Watery eyes<lb/> 2019 þ 2020<lb/> À0.296<lb/> À0.408 ~À0.176<lb/> &lt;0.001<lb/> 2019<lb/> À0.316<lb/> À0.509 ~À0.115<lb/> 0.003<lb/> 2020<lb/> À0.286<lb/> À0.425 ~À0.138<lb/> &lt;0.001</table>
		</figure>


		<figure type="table">

            <table>1.11 in<lb/> 0.72 pt<lb/> 0.19 pt<lb/> 0.57 pt<lb/> 0.31 pt<lb/> Asthma-mean 0.92<lb/> Asthma-SD?: 0.10<lb/> Asthma + mean: 0.77 (0.15)</table>
		</figure>


		<figure type="table">

            <head>Table </head>
 
            <label>4<lb/> </label>
<lb/> 
            <figDesc>Cost-utility analysis of SLIT for JCP.<lb/> </figDesc>
<lb/> 
            <table>Year<lb/> Group<lb/> Utility<lb/> QALY<lb/> SLIT<lb/> Rescue medication<lb/> ICER to placebo<lb/> (JPY/QALY)<lb/> 200 JAU bottle<lb/> (421.1 JPY)<lb/> 2000 JAU bottle<lb/> (1006.8 JPY)<lb/> 2000 JAU pack<lb/> (100.8 JPY)<lb/> Cost for<lb/> SLIT (JPY)<lb/> Fexofenadine<lb/> tablet (71.9 JPY)<lb/> Tramazoline nasal<lb/> drop (72 JPY/<lb/> 10 ml bottle)<lb/> Ketotifen eye<lb/> drop (720.2 JPY/5<lb/> ml bottle)<lb/> Cost for<lb/> rescue<lb/> medication (JPY)<lb/> 2011<lb/> Placebo<lb/> 0.864<lb/> ± 0.056<lb/> 0.216<lb/> ± 0.014<lb/> 0<lb/> 0<lb/> 0<lb/> 0<lb/> 12.3<lb/> ± 16.7<lb/> 1.2<lb/> ± 1.8<lb/> 2.6<lb/> ± 3.4<lb/> 2824.0<lb/> ± 3456.8<lb/> Active<lb/> 0.882<lb/> ± 0.056<lb/> 0.221<lb/> ± 0.014<lb/> 1<lb/> 1<lb/> 198<lb/> 21,386.3<lb/> 6.7<lb/> ± 4.9<lb/> 0.8<lb/> ± 1.5<lb/> 1.6<lb/> ± 2.7<lb/> 1686.3<lb/> ± 2145.1<lb/> 4,049,720<lb/> 2012<lb/> Placebo<lb/> 0.908<lb/> ± 0.058<lb/> 0.227<lb/> ± 0.014<lb/> 0<lb/> 0<lb/> 0<lb/> 0<lb/> 4.2<lb/> ± 10.1<lb/> 0.4<lb/> ± 1.0<lb/> 1.0<lb/> ± 2.1<lb/> 1073.0<lb/> ± 2113.0<lb/> Active<lb/> 0.931<lb/> ± 0.053<lb/> 0.233<lb/> ± 0.013<lb/> 0<lb/> 0<lb/> 363<lb/> 36,590.4<lb/> 1.9<lb/> ± 6.9<lb/> 0.2<lb/> ± 0.8<lb/> 0.6<lb/> ± 1.9<lb/> 549.9<lb/> ± 1777.3<lb/> 6,011,217</table>
		</figure>



    </text>
</tei>

